Filing Details
- Accession Number:
- 0001209191-10-058460
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-03 20:59:31
- Reporting Period:
- 2010-12-01
- Filing Date:
- 2010-12-03
- Accepted Time:
- 2010-12-03 20:59:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 858803 | Avanir Pharmaceuticals Inc. | AVNR | Pharmaceutical Preparations (2834) | 330314804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1280154 | Christine Ocampo | 101 Enterprise, Suite 300 Aliso Viejo CA 92656 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-01 | 11,250 | $0.00 | 53,232 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2010-12-02 | 24,000 | $1.74 | 77,232 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-02 | 24,000 | $4.15 | 53,232 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-12-03 | 14,350 | $1.74 | 67,582 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-03 | 14,350 | $4.03 | 53,232 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-12-03 | 9,000 | $0.88 | 62,232 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-03 | 9,000 | $4.03 | 53,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2010-12-01 | 72,500 | $0.00 | 72,500 | $4.18 |
| Common Stock | Stock Option (right to buy) | Disposition | 2010-12-02 | 24,000 | $0.00 | 24,000 | $1.74 |
| Common Stock | Stock Option (right to buy) | Disposition | 2010-12-03 | 14,350 | $0.00 | 14,350 | $1.74 |
| Common Stock | Stock Option (right to buy) | Disposition | 2010-12-03 | 9,000 | $0.00 | 9,000 | $0.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 72,500 | 2020-12-01 | No | 4 | A | Direct | |
| 129,400 | 2019-11-27 | No | 4 | M | Direct | |
| 115,050 | 2019-11-27 | No | 4 | M | Direct | |
| 39,000 | 2018-07-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 11,900 | Indirect | By spouse |
Footnotes
- Represents shares underlying Restricted Stock Units granted under the Issuer's 2005 Equity Incentive Plan that vest upon the satisfaction of certain performance milestones as follows: 50% of the underlying shares shall vest one year from achievement of the milestones and the remaining 50% of the underlying shares shall vest two years from achievement of the milestones.
- Not applicable.
- Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
- These shares are held by the Reporting Person's spouse, which are deemed beneficially owned by the Reporting Person.
- The option shall vest with respect to one-quarter of the underlying shares upon the first anniversary of December 1, 2010, and then with respect to the remaining shares quarterly thereafter over the next three years.
- The option vests with respect to one-quarter of the underlying shares upon the first anniversary of November 27, 2009, and then with respect to the remaining shares quarterly thereafter over the next three years.
- On July 25, 2008, the reporting person was granted an option to purchase up to 55,200 shares of common stock of the Issuer. The option vests and becomes exercisable following the achievement of certain performance goals relating to the clinical development of Zenvia, as follows: 55,200 shares will vest if the performance goals are met on or before December 31, 2008; 51,600 shares will vest if the performance goals are met between January 1 and February 15, 2009; 48,000 shares will vest if the performance goals are met between February 16 and March 31, 2009; 33,600 shares will vest if the performance goals are met between April 1 and June 30, 2009; and none of the shares will vest if the performance goals are met on or after July 1, 2009. Because the performance goals were met between February 16 and March 31, 2009, the reporting person was granted an option to purchase up to 48,000 shares of common stock of the Issuer.
- The option vested with respect to 6.25% of the underlying shares upon achievement of the performance goals and continues to vest with respect to 6.25% of the underlying shares on a quarterly basis over 15 quarters from the date of achievement of the performance goals.
Billionaire Hedge Funds
